Skip to main content
Caplight Logo









Helius Therapeutics

Helius Therapeutics

Private
AucklandHealthcare & Life Scienceshttps://helius.co.nz

Company Overview

Helius Therapeutics is a biotechnology company that specializes in the research, development, and manufacturing of medicinal cannabis products for the treatment of inflammatory and neurodegenerative conditions.

Sector

Healthcare & Life Sciences

Verticals

Biotechnology, Clinical Trials, Drug Discovery, Quality Management

Business Model

B2B

Customer Profile

Services & Consulting, Hardware Sales

AI Layer

Non-AI

Keywords

medicinal cannabismedical marijuanabiopharmaceuticalgood manufacturing practiceGMPcannabinoid extractsCBD oilTHC oilcontract manufacturingclinical trialscannabis researchpharmaceutical manufacturingbiotechcannabis export

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Helius Therapeutics Comparables

Compare Helius Therapeutics with similar companies based on industry and business-model similarity.

Helius Therapeutics comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
Organic Genetics
89%
Cannasouth Limited
88%
NUBU Pharmaceuticals
88%

Helius Therapeutics Funding Rounds

Historical fundraising activity

View Full Funding History

Access detailed round history, amounts raised, valuations, and investors.

Helius Therapeutics Filings

Explore SEC and related filing metadata, where available.

Helius Therapeutics filings preview — column headings only; records require access
TypeDateAmount OfferedAmount SoldFilingPagesDownload

Filing documents are not displayed on this public page. Request access to learn about available coverage.

Request access

Frequently Asked Questions

Common questions about Helius Therapeutics's valuation, stock price, and market status.

Is Helius Therapeutics a public or private company?

Helius Therapeutics is a private company.

What is the current stock price of Helius Therapeutics?

Helius Therapeutics is a private company with no public stock price. Caplight tracks Helius Therapeutics's secondary market activity and provides MarketPrice™ estimates to Caplight users.

How much is Helius Therapeutics worth (valuation)?

Valuation information for Helius Therapeutics is not publicly available.

Can I buy Helius Therapeutics stock?

Helius Therapeutics shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.

When was Helius Therapeutics's last funding round?

Funding round information for Helius Therapeutics is not publicly available.

Who are the main investors in Helius Therapeutics?

Investor information for Helius Therapeutics is not publicly disclosed.

Will Helius Therapeutics IPO soon?

No public IPO plans have been announced for Helius Therapeutics.

How can I track Helius Therapeutics secondary market activity?

Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor Helius Therapeutics's secondary market activity and sign up for updates.

Firmographic Details

HeadquartersAuckland
Year Founded2018
Last Funding—

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.

See something wrong or outdated?